Overexpression of Epstein-Barr virus-induced gene 3 protein (EBI3) in MRL/lpr mice suppresses their lupus nephritis by activating regulatory T cells

Autoimmunity

Volumn 46, Issue 7, 2013, Pages 446-454

  Shinsuke, Nishimura ^a   Hiroshi, Inoue ^a  

^a Murakami Memorial Hospital   (Japan)

Author keywords

Antibodies; Autoimmune response; Cytokines; Forkhead transcription factor 3; Glomerulonephritis

Indexed keywords

DOUBLE STRANDED DNA ANTIBODY; EPSTEIN BARR VIRUS INDUCED GENE 3 PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN E; MESSENGER RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; DIFFUSE PROLIFERATIVE GLOMERULONEPHRITIS; FLOW CYTOMETRY; GLOMERULONEPHRITIS; HISTOPATHOLOGY; INFLAMMATION; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 TH2 BALANCE; WILD TYPE;

ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; INFLAMMATION; INTERLEUKINS; LUPUS NEPHRITIS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED MRL LPR; MICE, TRANSGENIC; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS;

EID: 84885456696     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2013.809422     Document Type: Article

References (53)

1. Klinman, D. M., and A. D. Steinberg. 1995. Inquiry into murine and human lupus. Immunol Rev. 144: 157-193.
2. Theofilopoulos, A. N., and F. Dixon. 1985. Murine models of systemic lupus erythematosus. J Adv Immunol. 37: 269-390. (Pubitemid 15093080)
3. Romagnani, S. 1999. Th1/Th2 cells. Inflamm Bowel Dis. 5: 285-294.
4. Akahoshi, M., H. Nakashima, Y. Tanaka, T. Kohsaka, S. Nagano, E. Ohgami, Y. Arinobu, et al. 1999. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum. 42: 1644-1648. (Pubitemid 30263632)
5. Artis, D., A. Villarino, M. Silverman, W. He, E. M. Thornton, S. Mu, S. Summer, et al. 2004. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J Immunol. 173: 5626-5634. (Pubitemid 39392150)
6. Chen, Q., N. Ghilardi, H. Wang, T. Baker, M. H. Xie, A. Gurney, I. S. Grewal, et al. 2000. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature. 407: 916-920.
7. Masutani, K., M. Akahoshi, K. Tsuruya, M. Tokumoto, T. Ninomiya, T. Kohsaka, K. Fukuda, et al. 2001. Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum. 44: 2097-2106. (Pubitemid 33644053)
8. Shimizu, S., N. Sugiyama, K. Masutani, A. Sadanaga, Y. Miyazaki, Y. Inoue, M. Akahoshi, et al. 2005. Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1). J Immunol. 175: 7185-7192. (Pubitemid 41713412)
9. Yang, J., M. Yang, T. M. Htut, X. Ouyang, A. Hanidu, X. Li, R. Sellati, et al. 2008. Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma. Eur J Immunol. 38: 1204-1214.
10. Yoshida, H., S. Hamano, G. Senaldi, T. Covey, R. Faggioni, S. Mu, M. Xia, et al. 2001. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity. 15: 569-578. (Pubitemid 33016442)
11. Andrews, B. S., R. A. Eisenberg, A. N. Theofilopoulos, S. Izui, C. B. Wilson, P. J. McConahey, E. D. Murphy, et al. 1978. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 148: 1198-1215. (Pubitemid 9053639)
12. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 9: 243-269.
13. Sadanaga, A., H. Nakashima, M. Akahoshi, K. Masutani, K. Miyake, T. Igawa, N. Sugiyama, et al. 2007. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Arthritis Rheum. 56: 1618-1628. (Pubitemid 46764091)
14. Takahashi, S., L. Fossati, M. Iwamoto, R. Merino, R. Motta, T. Kobayakawa, S. Izui, et al. 1996. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mouse. J Clin Invest. 97: 1597-1604. (Pubitemid 26105469)
15. Haas, C., B. Ryffel, and M. Le Hir. 1997. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. J Immunol. 158: 5484-5491. (Pubitemid 127681257)
16. Kikawada, E., D. M. Lenda, and V. R. Kelley. 2003. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology. J Immunol. 170: 3915-3925. (Pubitemid 36359263)
17. Schwarting, A., T. Wada, K. Kinoshita, G. Tesch, and V. R. Kelley. 1998. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol. 161: 494-503. (Pubitemid 28285560)
18. Pflanz, S., J. C. Timans, J. Cheung, R. Rosales, H. Kanzler, J. Gilbert, L. Hibbert, et al. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(\+) T cells. Immunity. 16: 779-790. (Pubitemid 34786477)
19. Collison, L. W., C. J. Workman, T. T. Kuo, K. Boyd, Y. Wang, K. M. Vignali, R. Cross, et al. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 450: 566-569. (Pubitemid 350190247)
20. Devergne, O., M. Birkenbach, and E. Kieff. 1997. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci USA. 94: 12041-12046. (Pubitemid 27467839)
21. Niedbala, W., X. Q. Wei, B. Cai, A. J. Hueber, B. P. Leung, I. B. McInnes, and F. Y. Liew. 2007. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol. 37: 3021-3029. (Pubitemid 350131282)
22. Hamano, S., K. Himeno, Y. Miyazaki, K. Ishii, A. Yamanaka, A. Takeda, M. Zhang, et al. 2003. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity. 19: 657-667. (Pubitemid 37490791)
23. Hölscher, C., A. Hölscher, D. Rückerl, T. Yoshimoto, H. Yoshida, T. Mak, C. Saris, et al. 2005. The IL-27 receptor chain WSX-1 differentially regulates. Antibacterial immunity and survival during experimental tuberculosis. J Immunol. 174: 3534-3544. (Pubitemid 40354062)
24. Villarino, A., L. Hibbert, L. Lieberman, E. Wilson, T. Mak, H. Yoshida, R. A. Kastelein, et al. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity. 19: 645-655. (Pubitemid 37490790)
25. Kido, M., S. Takeuchi, N. Sugiyama, H. Esaki, H. Nakashima, H. Yoshida, and M. Furue. 2011. T cell-specific overexpression of interleukin-27 receptor a subunit (WSX-1) prevents spontaneous skin inflammation in MRL/lpr mice. Br J Dermatol. 164: 1214-1220.
26. Sugiyama, N., H. Nakashima, T. Yoshimura, A. Sadanaga, S. Shimizu, K. Masutani, T. Igawa, et al. 2008. Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1). Ann Rheum Dis. 67: 1461-1467.
27. Baecher-Allan, C., and D. A. Hafler. 2004. Suppressor T cells in human diseases. J Exp Med. 200: 273-276. (Pubitemid 39031246)
28. Banica, L., A. Besliu, G. Pistol, C. Stavaru, R. Ionescu, A. M. Forsea, C. Tanaseanu, et al. 2009. Quantification and molecular characterization of regulatory T cells in connective tissue diseases. Autoimmunity. 42: 41-49.
29. Bellinghausen, I., B. Klostermann, J. Knop, and J. Saloga. 2003. Human CD4\+CD25\+-T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J Allergy Clin Immunol. 111: 862-868. (Pubitemid 36470261)
30. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor FoxP3. Science. 299: 1057-1061. (Pubitemid 36222930)
31. Lourenço, E. V., A., and La Cava. 2001. Natural regulatory T cells in autoimmunity. Autoimmunity. 44: 33-42.
32. Zhou, X., N. Kong, H. Zou, D. Brand, X. Li, Z. Liu, and S. G. Zheng. 2011. Therapeutic potential of TGF-induced CD4(\+) Foxp3(\+) regulatory T cells in autoimmune diseases. Autoimmunity. 44: 43-50.
33. Atarashi, K., T. Tanoue, T. Shima, A. Imaoka, T. Kuwahara, Y. Momose, G. Cheng, et al. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 331: 337-341.
34. Ivanov, I. I., R. de L. Frutos, N. Manel, K. Yoshinaga, D. B. Rifkin, R. B. Sartor, B. B. Finlay, et al. 2008. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 4: 337-349.
35. Igawa, T., H. Nakashima, A. Sadanaga, K. Masutani, K. Miyake, S. Shimizu, A. Takeda, et al. 2009. Deficiency in EBV-induced gene 3 (EBI3) in MRL/lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis. Mod Rheumatol. 19: 33-41.
36. Sakaguchi, S. 2005. Naturally arising Foxp3-expressing CD25\+CD4\+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 6: 345-352. (Pubitemid 41716771)
37. Shevach, E. M. 2003. CD4\+ CD25\+ suppressor T cells: more questions than answers. Nat Rev Immunol. 2: 389-400.
38. Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of CD4\+CD25\+ regulatory T cells. Nat Immunol. 4: 330-336. (Pubitemid 36432314)
39. Khattri, R., T. Cox, S. A. Yasayko, and F. Ramsdell. 2003. An essential role for Scurfin in CD4\+CD25\+-T regulatory cells. Nat Immunol. 4: 337-342. (Pubitemid 36432315)
40. Ouyang, Y., A. Nakano, E. Fan, Y. Li, L. Zhao, W. Zhang, D. Han, et al. 2011. Decreased expression of EBI3 and Foxp3 in CD4\+CD25\+ regulatory T cells in murine experimental allergic rhinitis. ORL; J Otorhinolaryngol Relat Spec. 73: 313-320.
41. Ling, E. M., T. Smith, X. D. Nguyen, C. Pridgeon, M. Dallman, J. Arbery, V. A. Carr, and D. S. Robinson. 2004. Relation of CD4\+CD25\+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet. 363: 608-615. (Pubitemid 38264178)
42. Komatsu, N., M. E. Mariotti-Ferrandiz, Y. Wang, B. Malissen, H. Waldmann, and S. Hori. 2009. Heterogeneity of natural Foxp3\+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci USA. 106: 1903-1908.
43. Fransson, M., J. Burman, C. Lindqvist, C. Atterby, J. Fagius, and A. Loskog. 2010. T regulatory cells lacking CD25 are increased in MS during relapse. Autoimmunity. 43: 590-597.
44. Lucas, S., N. Ghilardi, J. Li, and F. J. de Sauvage. 2003. IL-27 regulates IL-12 responsiveness of naive CD4\+ T cells through Stat1-dependent and-independent mechanisms. Proc Natl Acad Sci USA. 100: 15047-15052. (Pubitemid 37518014)
45. Owaki, T., M. Asakawa, N. Morishima, K. Hata, F. Fukai, M. Matsui, J. Mizuguchi, et al. 2005. A role for IL-27 in early regulation of Th1 differentiation. J Immunol. 175: 2191-2200. (Pubitemid 41113825)
46. Takeda, A., S. Hamano, A. Yamanaka, T. Hanada, T. Ishibashi, T. W. Mak, A. Yoshimura, et al. 2003. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol. 170: 4886-4890. (Pubitemid 36554716)
47. Yoshimoto, T., T. Yoshimoto, K. Yasuda, J. Mizuguchi, and K. Nakanishi. 2007. L-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation. J Immunol. 179: 4415-4423.
48. Batten, M., J. Li, S. Yi, N. M. Kljavin, D. M. Danilenko, S. Lucas, J. Lee, et al. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol. 7: 929-936. (Pubitemid 44263906)
49. Stumhofer, J. S., A. Laurence, E. H. Wilson, E. Huang, C. M. Tato, L. M. Johnson, A. V. Villarino, et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol. 7: 937-945. (Pubitemid 44263907)
50. Collison, L. W., V. Chaturvedi, A. L. Henderson, P. R. Giacomin, C. Guy, J. Bankoti, D. Finkelstein, et al. 2010. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol. 11: 1093-1101.
51. Nieuwenhuis, E. E., M. F. Neurath, N. Corazza, H. Iijima, J. Trgovcich, S. Wirtz, J. Glickman, et al. 2002. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc Natl Acad Sci USA. 99: 16951-16956. (Pubitemid 36034079)
52. Zahn, S., S. Wirtz, M. Birkenbach, R. S. Blumberg, M. F. Neurath, and E. von Stebut. 2005. Impaired Th1 responses in mice deficient in Epstein-Barr virus-induced gene 3 and challenged with physiological doses of Leishmania major. Eur J Immunol. 35: 1106-1112. (Pubitemid 40542217)
53. Yang, X. O., R. Nurieva, G. J. Martinez, H. S. Kang, Y. Chung, B. P. Pappu, B. Shah, et al. 2008. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity. 29: 44-56.